Target intelligence / Profile preview

RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P)

Target
RNU6-1099P
Molecular classification
Pseudogene, Long non-coding RNA (potentially, if transcribed), Small nuclear RNA-related family (by homology, not by function)
01

Overview

RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P) is a processed pseudogene found in humans that resembles the U6 small nuclear RNA gene, an essential component of spliceosomal snRNPs involved in mRNA splicing[1][3]. Unlike the functional U6 snRNA, RNU6-1099P does not produce a functional product and is categorized as a non-coding genetic element. While pseudogenes can play regulatory roles at the RNA level—such as acting as decoys for miRNAs or producing non-coding RNAs that modulate gene expression—there are currently no specific functional, pathogenic, or pharmacological roles documented for RNU6-1099P[1][2]. Its classification as a pseudogene implies that it should not be construed as a direct drug target or conventional receptor/enzyme/transporter. The inclusion of this entity may reflect erroneous or overly broad target selection for drug discovery or mechanistic studies[1][2].

Other names
RNU6-1099PRNA, U6 small nuclear 1099, pseudogene
02

Mechanism of action

Not applicable (no drugs or interventions directly target RNU6-1099P specifically)

03

Biological functions

May act in regulation of gene expression through mechanisms typical of pseudogenes: e.g., miRNA decoy, competition for RNA-binding proteins, production of endogenous siRNAs, or long non-coding RNAs that modulate epigenetic regulatorsNo known direct biological function, as annotation is limited to pseudogenes and not functional snRNA
04

Disease associations

Pseudogenes as a class have been implicated in various cancer types (as ceRNAs, miRNA decoys, or epigenetic regulators)No disease role specifically established for RNU6-1099P
05

Safety considerations

None known (pseudogenes are generally not considered for therapeutic intervention)
06

Interacting drugs

None known (pseudogenes are not direct drug targets)
07

Biomarkers

None known for patient selection or efficacy monitoring in clinical context

Beyond the preview

Go deeper on RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call